Apatinib

CAS No. 811803-05-1

Apatinib( YN968D1 )

Catalog No. M16035 CAS No. 811803-05-1

Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 76 In Stock
5MG 108 In Stock
10MG 137 In Stock
25MG 233 In Stock
50MG 350 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Apatinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.
  • Description
    Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    YN968D1
  • Pathway
    Angiogenesis
  • Target
    c-Kit
  • Recptor
    c-Kit| RET| c-Src| VEGFR2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    811803-05-1
  • Formula Weight
    397.48
  • Molecular Formula
    C24H23N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 22 mg/mL (44.57 mM)
  • SMILES
    CS(O)(=O)=O.O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tian S, et al. Y Sci, 2011, 102(7), 1374-1380.
molnova catalog
related products
  • Masitinib mesylate

    A potent tyrosine kinase inhibitor targeting c-Kit and PDGFR with IC50 of 0.15 and 0.05 uM in cell based assays.

  • Amuvatinib

    A novel RTK inhibitor that effectively inhibits c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively.

  • CS-2660

    CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.